Gemcitabine, Cisplatin, and Nab-Paclitaxel vs Gemcitabine and Cisplatin for Newly Diagnosed Advanced Biliary Tract Cancers
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
J. Clin. Oncol 2024 Dec 13;[EPub Ahead of Print], RT Shroff, G King, S Colby, AJ Scott, MJ Borad, L Goff, K Matin, A Mahipal, A Kalyan, MM Javle, I El Dika, B Tan, P Cheema, A Patel, R Iyer, RK Kelley, J Thumar, A El-Khoueiry, KA Guthrie, EG Chiorean, H Hochster, PA PhilipFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.